Ocular symptoms in association with antiphospholipid antibodies

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 236, Issue 9, 1998, Pages 658-668

  Leo Kottler, Beate ^a   Klein, Reinhild ^a   Berg, Peter A ^a   Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; ANTITHROMBOCYTIC AGENT; CARDIOLIPIN; DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOROID VASCULARIZATION; CLINICAL ARTICLE; EYE DISEASE; FEMALE; HUMAN; LABORATORY TEST; MALE; OPHTHALMOSCOPY; OPTIC NERVE ATROPHY; PERIMETRY; PRIORITY JOURNAL; SLIT LAMP; TONOMETRY; TRANSITIONAL BLINDNESS; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 0031750930     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050138     Document Type: Article

References (86)

1. Alarćon-Segovia D. Cabrai A (1994) Antiphospholipid antibodies: Where do they come from? Where do they go to? J Rheumatol 21:982-989
2. Alarćon-Segovia D, Deleze M, Oria CV, et al. (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients. Medicine 68:353-374
3. Alarćon-Segovia D, Perez-Vazquez ME, Villa AR, et al. (1992) Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 21:275-286
4. Alving BM, Barr CF, Johansen LE, Tang DB (1992) Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants. Thromb Haemost 67:672-678
5. Asherson RA, Cervera R (1995) Review: antiphospholipid antibodies and the lung. J Rheumatol 22:62-66
6. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguiley E, Hughes GRV (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 86:391-399
7. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GRV (1989) Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the "primary" antiphospholipid syndrome. Ann Rheum Dis 48:358-361
8. Bertram B, Haase G, Remky A, Reim M (1994) Anti-Cardiolipin-Antikörper bei Gefäßverschlüssen am Auge. Ophthalmologe 91:768-771
9. Bouanani M, Picchaczyk M, Pau B, Bastide M (1989) Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects. J Immunol 143:1129-1132
10. Bouchou K, Andre M, Cathebras P, Klisnick A, Schmidt J, Aumaitre O, Rousset H (1995) Thyroid antibodies and multiple autoimmune syndromes. Clinical and immunogenetic aspects apropos of 11 cases. Rev Med Intern 16:283-287
11. Branch DW, Rote NS, Scott JR (1986) The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay. Clin Immunol Immunopathol 39:298-307
12. Brey RL, Coull BM (1992) Antiphospholipid antibodies: origin, specificity, and mechanism of action. Stroke 23 [Suppl I]: 15-18
13. Brey RL, Gharavi AE, Lockshin MD (1993) Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin North Am 19:833-850
14. Briley DP, Coull BM, Goodnight SH (1989) Neurological disease associated with antiphospholipid antibodies. Ann Neural 25:221-227
15. Castañón C, Amigo MC, Banales JL, Nava A, Reyes PA (1995) Ocular vasoocclusive disease in primary antiphospholipid syndrome. Ophthalmology 102:256-262
16. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R, Mariani G (1996) Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions. Thromb Res 83:183-188
17. Cuadrado MJ, López-Pedrera C, Khamashta MA, Camps MT, Tinahones F, Torres A, Hughes GRV, Velasco F (1997) Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 40:834-841
18. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Hughes GRV. Meroni PL (1997) Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 40:551-561
19. Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR (1989) Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 25:228-232
20. Drance SM, Sweeney VP, Morgan RW, Feldman F (1973) Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 89:457-465
21. Feldmann E, Levine SR (1995) Cerebrovascualr disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. Ann Neurol 37 [Suppl 1]:S114-130
22. Galetta SL, Plock GL, Kushner MJ, Wyszynski RE, Bruckner AJ (1991) Ocular thrombosis associated with antiphospholipid antibodies. Ann Ophthalmol 23:207-212
23. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T (1997) Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 77:486-491
24. Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE (1997) Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 37:118-124
25. Gerber SL, Cantor LB (1990) Progressive optic atrophy and the primary antiphospholipid antibody syndrome. Am J Ophthalmol 110:443-444
26. Glacet-Bernard A, Bayani N, Chretien P, Cochard C, Lelong F, Coscas G (1994) Antiphospholipid antibodies in retinal vascular occlusions. Arch Ophthalmol 112:790-795
27. Gobert A (1995) Sneddon's syndrome with bilateral peripheral retinal neovascularization. Bull Soc Belge Ophthalmol 255:85-90
28. Goldberg I, Hollows FC, Kass MA, Becker B (1981) Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol 65:56-62
29. Graham EM (1990) The investigation of patients with retinal vascular occlusion. Eye 4:464-468
30. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV (1994) Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 37:568-571
31. Hess DC (1992) Stroke associated with antiphospholipid antibodies. Stroke 23 [Suppl 2]: 123-128
32. Hiller E, Roth W, Wahl R, Kallee E (1975) Thrombokinaseaktivität von Schilddrüsenextrakten. Klin Wochenschr 53:283-284
33. Hirashima Y, Kurimoto M, Tsukamoto E, Endo S, Takaku A (1995) Antiphospholipid antibodies and cerebral vasospasms following subarachnoid haemorrhage. Acta Neurochir Wien 135:191-197
34. Hofbauer LC, Heufelder AE (1997) Coagulation disorders in thyroid diseases. Eur J Endocrinol 136:1-7
35. Hofbauer LC, Spitzweg C, Heufelder AE (1996) Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 23:1435-1437
36. Hoyng PFJ, de Jong N, Ousting H, Stilma J (1992) Platelet aggregation, disc haemorrhage and progressive loss of visual fields in glaucoma: seven year follow-up study on glaucoma. Int Ophthalmol 16:65-73
37. Hughes GRV (1985) Anti-cardiolipin syndrome. Clin Exp Rheumatol 3:285-286
38. Hughes GRV (1993) The antiphospholipid syndrome: ten years on. Lancet 342:341-344
39. Insko EK, Haskal ZJ (1997) Antiphospholipid syndrome: patterns of lifethreatening and severe recurrent vascular complications. Radiology 202:319-326
40. Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 104:558-563
41. Joist JH (1990) Hypercoagulability: introduction and perspective. Semin Thromb Hemost 16:65-73
42. Jonas J, Koelble K, Voelcker HE, Kalden JR (1986) Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol 102:37-40
43. Kaaja R, Julkunen H, Viinikka L, Ylikorkala O (1993) Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin. Obstet Gynecol 81:327-331
44. Kalashnikova LA, Nasonov EL, Stoyanovich LZ, Kovalyov VU, Kosheleva NM, Reshetnyak TM (1994) Sneddon's syndrome and the primary antiphospholipid syndrome. Cerebrovasc Dis 4:76-82
45. Kato T, Morita A, Matsumoto Y (1997) Hypoperfusion of brain single photon emission computerized tomography in patients with antiphospholipid antibodies. J Dermatol Sci 14:20-28
46. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993-997
47. Khamashta MA, Hughes GRV (1995) Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 7:389-394
48. Klein R, Richter P, Berg PA (1991) Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and Western blotting: marker antibodies to neuropsychiatric manifestations in connective tissue disorders. Autoimmunity 10:133-134
49. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ (1989) Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 96:896-904
50. Kornberg A, Blank M, Kaufman S, Shoenfefd Y (1994) Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies. J Immunol 153:1328-1332
51. Krakau CET (1994) Disk hemorrhages and retinal vein occlusions in glaucoma. Surv Ophthalmol 38 [Suppl]:S18-22
52. Levine SR, Welch KMA (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies. Arch Neurol 44:876-883
53. Levine SR, Crofts JW, Lesser GW, Floberg J, Welch KMA (1988) Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 95:686-692
54. Levine SR, Deegan MJ, Futrell N, Welch KMA (1990) Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 40:1181-1189
55. Lindsey NJ, Henderson FI, Malia R, Milford-Ward MA, Greaves M, Hughes P (1994) Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 33:20-26
56. López-Soto A, Casals FJ, Font J, Cervera R, Ingelmo M (1989) Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen. Thromb Res 53:623-662
57. Marongiu R, Conti M, Murtas ML, et al. (1991) Anticardiolipin antibodies in Graves' disease: Relationship with thrombin activity in vivo. Thromb Res 64:745-749
58. Matsuda J, Saitoh N, Gotoh M, Gohchi K, Tsukamoto M, Syoji S, Miyake K, Yamanaka M (1995) High prevalence of anti-phospholipid antibodies in patients with hepatitis C virus infection treated with interferon-alpha. Am J Gastroenterol 90:1138-1141
59. Miller NR (1991) Cerebrovascular disease. In: Miller NR (ed) Walsh and Hoyt's clinical neuro-ophthalmology. Williams & Wilkins, Baltimore, p 2337
60. Miller NR (1991) Migraine. In: Miller NR (ed) Walsh and Hoyt's clinical neuro-ophthalmology. Williams & Wilkins, Baltimore, pp 2530, 2551-2556
61. O'Brien C, Butt Z, Ludlam C, Detkova P (1997) Activation of the coagulation cascade in untreated primary open-angle glaucoma. Ophthalmology 104:725-730
62. Ohtani H, Imai H, Yasuda T, Wakui H, Komatsuda A, Hamai K, Miura AB (1995) A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon's syndrome. Am J Kidney Dis 26:511-515
63. Oosting JD, Derksen RHWM, Bobbink JWG, Hackeng TM, Bouma B, de Groot PG (1993) Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S - an explanation for their pathogenic mechanism? Blood 81:2618-2625
64. Pelletier S, Landi B, Piette JC, Ekert P, Coutellier A, Desmoulins C, Fadlallah JP, Herson S, Valla D (1994) Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 21:76-80
65. Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T (1997) Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost 77:123-126
66. Petri M (1997) Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 81:151-177
67. Pierangeli SS, Harris EN (1994) Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 3:247-251
68. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N (1993) Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 168:837-841
69. Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314:253-257
70. Richard G (1992) Disturbances of the choroidal circulation. In: Richard G (ed) Choroidal circulation. Thieme, New York, p 96
71. Robbins L (1991) Migraine and anticardiolipin antibodies - case reports of 13 patients, and the prevalence of antiphospholipid antibodies in migraineurs. Headache 31:537-539
72. Shimizu K, Numaga J, Takahashi M, Matsunaga T (1995) A case of Sneddon syndrome. (abstract) Nippon Ganka Gakkai Zasshi 99:104-108
73. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW (1994) Clinical consequences of antiphospholipid antibodies: a historic cohort study. Obstet Gynecol 83:372-377
74. Silvestrini M, Matteis M, Troisi E, Cupini LM, Zaccari G, Bernardi G (1994) Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 34:316-319
75. Snyers B, Lambert M, Hardy JP (1990) Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 10:255-260
76. Thiagarajan P, Pengo V, Shapiro SS (1986) The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 68:869-874
77. Thomas P, Lebrun C, Mahagne MH, Desnuelles C, Chatel M (1993) Encéphalopathie ischémique au cours d'un syndrome primaire des anticorps antiphospholipides. Rev Neurol (Paris) 149:336-339
78. Tomer Y, Gilburd B, Sack J, Davies TF, Meshorer A, Burek CL, Rose NR, Schoenfeld Y (1996) Induction of thyroid antibodies in naive mice by idiotypic manipulation. Clin Immunol Immunopathol 78:180-187
79. Tsakiris DA, de Moerloose P (1993) Das Antiphospholipid-Syndrom: eine neue klinische Entität? Schweiz Med Wochenschr 123:2183-2190
80. Tsakiris DA, Osusky R, Kaiser HJ, Mueri R, Flammer J, Marbet GA (1992) Lupus anticoagulants/anticardiolipin antibodies in patients with normal tension glaucoma. Blood Coagulat Fibrinolysis 3:541-545
81. Vahl AC, Gans RO, Mackaay AJ, van der Waal C, Rauwerda JA (1997) Superior mesenteric artery occlusion and peripheral emboli caused by an aortic ulcer in a young patient with antiphospholipid syndrome. Surgery 121:588-590
82. Vasquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcón-Segovia D (1994) Exposure of anionic phospholipids upon platelet activation permits binding of β 2 glycoprotein I and through it that of IgG antiphospholipid antibodies: studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 7:335-348
83. Vrethem M, Enerudh J, Lindstrom F, Olsson JE (1992) Cerebral ischemia associated with anticardiolipin antibodies. Acta Neurol Scand 85:412-417
84. Watts MT, Greaves M, Clearkin LG, Malia RG, Cooper SM (1990) Antiphospholipid antibodies and ischaemic optic neuropathy. Lancet 335:613-614
85. Watts MT, Greaves M, Rennie IG, Clearkin LG (1991) Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy. Eye 5:75-79
86. Weller M, Leo-Kottler B, Berg PA, Wiethölter H (1991) Antiphospholipid-Syndrom. Neurologische Komplikationen und therapeutische Möglichkeiten. Dtsch Med Wochenschr 116:1794-1796